sphingosine-1-phosphate receptor-1 antagonists (AstraZeneca Pharmaceuticals LP)

N/A

Report date: 2025/03/20 10:11:56
NME

Base Information

Drug Namesphingosine-1-phosphate receptor-1 antagonists (AstraZeneca Pharmaceuticals LP)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 antagonists
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsInflammationAutoimmune DiseasesDiabetes Mellitus +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Pharmaceuticals Lp
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceuticals Lp
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesDiabetes Mellitus +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A